Winn Awards, shared a post on LinkedIn:
“At the 2026 BIO International Convention, leaders from across academia, industry, and the Winn Awards community came together to explore how we can build more representative and accessible clinical trials.
Thank you to the outstanding panelists who shared their perspectives during ‘Equity by Design: Reimagining Clinical Trials‘:
- Amanda Beasley, PhD, Amgen, Winn Awards funding partner.
- Altovise T. Ewing-Crawford, PhD, LCGC, Genentech, Winn Awards funding partner.
- Mattheus Ramsis, MD, Winn CDA and Winn CILA scholar.
- Joy L. Jones, PhD, Winn CIPP.
The conversation highlighted the importance of designing clinical research with communities at the center. Because better trial design leads to Better Science For All.”
Other articles about BIO 2026 on OncoDaily.